Growth in Formulation & Synthesis Segment with a decline in API segment coupled with inflationary pressure led to dismal | Laurus Labs Q2 FY22 Result & Earning Call
Growth in Formulation & Synthesis Segment with a decline in API segment coupled with inflationary pressure led to dismal | Laurus Labs Q2 FY22 Result & Earning Call
Growth in Formulation & Synthesis Segment with a decline in API segment coupled with inflationary pressure led to dismal | Laurus Labs Q2 FY22 Result & Earning Call
Published on 02 November 2021 .Views 127.Comments 2
Download
